AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

JUDGES SCIENTIFIC PLC

Director's Dealing Jul 9, 2013

7734_dirs_2013-07-09_15974ebc-bdbf-4f4d-8ef5-40fffc7ece07.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8577I

Judges Scientific PLC

09 July 2013

Judges Scientific plc (the "Company")

9 July 2013

Exercise of Options & Director/PDMR Shareholding

Exercise of Options: Judges Scientific plc yesterday issued 1,000 new Ordinary Shares of 5p each in the Company ("Ordinary Shares") pursuant to the exercise of options under the Company's Approved Share Option Scheme. Application has been made for the new Ordinary Shares to be admitted to AIM and dealings are expected to commence on 12 July 2013.

Following the exercise of these options, the enlarged issued share capital of the Company will be 5,319,999 Ordinary Shares.

Share Incentive Plan: the Company has also been advised that purchases of Ordinary Shares were made on Friday 5 July 2013 by the Trustees of the Share Incentive Plan on behalf of two Directors of the Company, as follows:

A total of eight Ordinary Shares were purchased on behalf of David Cicurel, the Chief Executive Officer of the Company, to which the Company added a further eight Ordinary Shares under the "matching" provisions of the Plan rules.  His resulting interest in the Company is 916,338 Ordinary Shares representing 17.22 per cent of the issued Ordinary share capital.

A total of eight Ordinary Shares were purchased on behalf of Ralph Cohen, the Finance Director of the Company, to which the Company added a further eight Ordinary Shares under the "matching" provisions of the Plan rules.  His resulting interest in the Company is 50,857 Ordinary Shares representing 0.95 per cent of the issued Ordinary share capital.  In addition, he holds options over 43,100 Ordinary Shares under the Company's Share Option Plans.

The purchases by the Trustees were made at a price of 1455.0p per Ordinary Share.  Purchases of a further 519 Ordinary Shares were made on the same date and at the same price on behalf of 52 other members of staff under the Plan.

For further information please contact:

Judges Scientific Plc

David Cicurel, CEO

Tel: 01342 323 600

Shore Capital (Nominated Adviser & Broker)

Pascal Keane

Edward Mansfield

Tel: 020 7408 4090

Cardew Group (Financial Public Relations)

Melvyn Marckus

Tel: 07775 896 491

Website:

Judges Scientific: www.judges.uk.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBIGDRRUGBGXI

Talk to a Data Expert

Have a question? We'll get back to you promptly.